tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

AMS Announces Shareholding Transaction by CEO Chris Meredith

Story Highlights
AMS Announces Shareholding Transaction by CEO Chris Meredith

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Advanced Medical Solutions ( (GB:AMS) ) has shared an update.

Advanced Medical Solutions Group plc announced a shareholding transaction involving its CEO, Chris Meredith, who transferred 50,510 Ordinary Shares through sale and repurchase to various personal accounts, including Individual Savings Accounts and Self-Invested Personal Pensions. This transaction, which maintains the beneficial ownership of shares unchanged, is part of routine tax planning and does not impact the company’s operations or market positioning.

The most recent analyst rating on (GB:AMS) stock is a Hold with a £221.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.

Spark’s Take on GB:AMS Stock

According to Spark, TipRanks’ AI Analyst, GB:AMS is a Neutral.

The overall stock score of 64 reflects strong financial performance with robust revenue growth and a solid capital structure. However, high P/E ratio and declining profitability margins are concerns. Technical indicators show a positive trend, but valuation metrics suggest caution.

To see Spark’s full report on GB:AMS stock, click here.

More about Advanced Medical Solutions

Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer specializing in innovative tissue-healing technologies. The company offers a diverse range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under various brand names such as LiquiBand, RESORBA, and Seal-G. AMS also provides wound care dressings and has expanded its portfolio through multiple acquisitions since 2019. With manufacturing facilities in several countries and a global distribution network, AMS focuses on delivering quality outcomes for patients and value for payers.

Average Trading Volume: 414,703

Technical Sentiment Signal: Buy

Current Market Cap: £481.3M

See more data about AMS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1